loadpatents
name:-0.050932168960571
name:-0.025110006332397
name:-0.010296821594238
Stockwell; Brent R. Patent Filings

Stockwell; Brent R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stockwell; Brent R..The latest application filed is for "methods of enhancing radiotherapy using ferroptosis inducers as radiosensitizers".

Company Profile
9.25.47
  • Stockwell; Brent R. - New York NY
  • STOCKWELL; BRENT R. - NEW YOK NY
  • Stockwell; Brent R - New York NY
  • Stockwell; Brent R. - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Enhancing Radiotherapy Using Ferroptosis Inducers As Radiosensitizers
App 20220193047 - Stockwell; Brent R. ;   et al.
2022-06-23
Compounds And Compositions That Cause Mycn And/or Cmyc Degradation And Methods Of Use Thereof
App 20220119399 - Stockwell; Brent R. ;   et al.
2022-04-21
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
Grant 11,192,849 - Stockwell , et al. December 7, 2
2021-12-07
Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders
App 20210299107 - Stockwell; Brent R. ;   et al.
2021-09-30
Nanoparticle Formulations Of Ike And Methods Of Use Thereof
App 20210267978 - Stockwell; Brent R. ;   et al.
2021-09-02
Small molecule ferroptosis inducers
Grant 10,947,188 - Stockwell , et al. March 16, 2
2021-03-16
Compounds, Compositions, And Methods For Suppressing Toxic Endoplasmic Reticulum Stress
App 20210040091 - STOCKWELL; BRENT R. ;   et al.
2021-02-11
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
Grant 10,597,381 - Stockwell , et al.
2020-03-24
Small Molecule Ferroptosis Inducers
App 20190315681 - Stockwell; Brent R. ;   et al.
2019-10-17
Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders
App 20190292135 - Stockwell; Brent R. ;   et al.
2019-09-26
Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders
App 20190135782 - Stockwell; Brent R. ;   et al.
2019-05-09
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
Grant 10,259,775 - Stockwell , et al.
2019-04-16
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
Grant 10,233,171 - Stockwell , et al.
2019-03-19
Carbonyl erastin analogs and their use
Grant 9,938,245 - Stockwell , et al. April 10, 2
2018-04-10
Small Molecule Oxidizers Of Pdi And Their Use
App 20180092908 - Stockwell; Brent R. ;   et al.
2018-04-05
Multivalent RAS binding compounds
Grant 9,926,293 - Stockwell , et al. March 27, 2
2018-03-27
Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders
App 20170233370 - Stockwell; Brent R. ;   et al.
2017-08-17
Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use
Grant 9,695,133 - Stockwell , et al. July 4, 2
2017-07-04
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
Grant 9,580,398 - Stockwell , et al. February 28, 2
2017-02-28
Carbonyl Erastin Analogs And Their Use
App 20160332974 - Stockwell; Brent R. ;   et al.
2016-11-17
Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders
App 20160297748 - Stockwell; Brent R. ;   et al.
2016-10-13
Multivalent Ras Binding Compounds
App 20160229836 - Stockwell; Brent R. ;   et al.
2016-08-11
Quinazolinone-based Oncogenic-ras-selective Lethal Compounds And Their Use
App 20150175558 - Stockwell; Brent R ;   et al.
2015-06-25
Compounds, Compositions, and Methods For Modulating Ferroptosis and Treating Excitotoxic Disorders
App 20150079035 - Stockwell; Brent R. ;   et al.
2015-03-19
Oncogenic-RAS-signal dependent lethal compounds
Grant 8,546,421 - Stockwell , et al. October 1, 2
2013-10-01
Assays for non-apoptotic cell death and uses thereof
Grant 8,535,897 - Stockwell September 17, 2
2013-09-17
Quinoxaline derivatives as antitumor agents
Grant 8,518,959 - Becklin , et al. August 27, 2
2013-08-27
E3 Ligase Inhibitors
App 20120135089 - Stockwell; Brent R. ;   et al.
2012-05-31
Identification of genotype-selective anti-tumor agents
Grant 8,124,365 - Stockwell February 28, 2
2012-02-28
Assays For Non-apoptotic Cell Death And Uses Thereof
App 20110008803 - Stockwell; Brent R.
2011-01-13
Oncogenic-RAS-signal dependent lethal compounds
App 20100081654 - Stockwell; Brent R. ;   et al.
2010-04-01
Identification Of Anti-cancer Compounds And Compounds For Treating Huntington's Disease And Methods Of Treatment Thereof
App 20100022637 - Stockwell; Brent R. ;   et al.
2010-01-28
Erastin and erastin binding proteins, and uses thereof
Grant 7,615,554 - Selliah , et al. November 10, 2
2009-11-10
Quinoxaline Derivatives as Antitumor Agents
App 20090214465 - Becklin; Robert R. ;   et al.
2009-08-27
SMA Therapy and Cell Based Assay
App 20090031435 - Stockwell; Brent R. ;   et al.
2009-01-29
Method Of High-throughput Screening Of Molecules And Compounds For Their Effects On Biological And Chemical Processes
App 20080311589 - Stockwell; Brent R. ;   et al.
2008-12-18
Compunds and compositions that cause non-apoptotic cell death and uses thereof
App 20080299076 - Stockwell; Brent R.
2008-12-04
Identification of genotype- selective anti-tumor agents
App 20080220454 - Stockwell; Brent R.
2008-09-11
Screening system for identifying drug-drug interactions and methods of use thereof
App 20080194421 - Borisy; Alexis ;   et al.
2008-08-14
Identification of genotype-selective anti-tumor agents
Grant 7,358,262 - Stockwell April 15, 2
2008-04-15
Erastin analogs and uses thereof
App 20070161644 - Stockwell; Brent R.
2007-07-12
Agents For Treating Neurodegenerative Diseases
App 20070149543 - Stockwell; Brent R. ;   et al.
2007-06-28
Combinations of drugs for the treatment of neoplasms
App 20070099905 - Borisy; Alexis ;   et al.
2007-05-03
Combinations for the treatment of noeplastic disorders
App 20070099906 - Borisy; Alexis ;   et al.
2007-05-03
Agents for treating neurodegenerative diseases
App 20070078144 - Stockwell; Brent R. ;   et al.
2007-04-05
Agents for treating neurodegenerative diseases
App 20070027164 - Stockwell; Brent R. ;   et al.
2007-02-01
Combinations of drugs for the treatment of neoplastic disorders
Grant 7,148,216 - Borisy , et al. December 12, 2
2006-12-12
Erastin and erastin binding proteins, and uses thereof
App 20060211683 - Selliah; Robert ;   et al.
2006-09-21
Synthesis of combinatorial libraries of compounds reminiscent of natural products
Grant 7,109,377 - Schreiber , et al. September 19, 2
2006-09-19
Treatments for neurotoxicity in Alzheimer's Disease
Grant 7,101,879 - Ingram , et al. September 5, 2
2006-09-05
Methods For Identifying Combinations Of Entities As Therapeutics
App 20060177877 - STOCKWELL; Brent R. ;   et al.
2006-08-10
Treatments for neurotoxicity in Alzheimer's Disease
Grant 7,067,550 - Ingram , et al. June 27, 2
2006-06-27
Combinations of drugs for the treatment of neoplastic disorders
App 20050192274 - Borisy, Alexis ;   et al.
2005-09-01
Identification of genotype-selective agents for treating Huntington's disease
App 20050032124 - Stockwell, Brent R. ;   et al.
2005-02-10
Combinations of drugs for the treatment of neoplastic disorders
Grant 6,846,816 - Borisy , et al. January 25, 2
2005-01-25
Identification of genotype-selective anti-tumor agents
App 20040248221 - Stockwell, Brent R.
2004-12-09
Combinations of drugs for the treatment of neoplasms
App 20040116407 - Borisy, Alexis ;   et al.
2004-06-17
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
App 20040063769 - Borisy, Alexis ;   et al.
2004-04-01
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
Grant 6,693,125 - Borisy , et al. February 17, 2
2004-02-17
Combinations of drugs for the treatment of neoplastic disorders
App 20030166642 - Borisy, Alexis ;   et al.
2003-09-04
Treatments for neurotoxicity in alzheimer's disease
App 20030114510 - Ingram, Vernon M. ;   et al.
2003-06-19
Treatments for neurotoxicity in Alzheimer's disease
App 20030105152 - Ingram, Vernon M. ;   et al.
2003-06-05
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
Grant 6,569,853 - Borisy , et al. May 27, 2
2003-05-27
Screening system for identifying drug-drug interactions and methods of use thereof
App 20030096309 - Borisy, Alexis ;   et al.
2003-05-22
Synthesis of combinatorial libraries of compounds reminiscent of natural products
App 20030082830 - Schreiber, Stuart L. ;   et al.
2003-05-01
Small molecule microarrays
App 20030032203 - Sabatini, David M. ;   et al.
2003-02-13
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
App 20020165261 - Borisy, Alexis ;   et al.
2002-11-07
Methods for identifying combinations of entities as therapeutics
App 20020019011 - Stockwell, Brent R. ;   et al.
2002-02-14
Methods for identifying combinations of entities as therapeutics
App 20020019010 - Stockwell, Brent R. ;   et al.
2002-02-14
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed